Canopy Growth (TSE:WEED – Get Free Report) had its target price lowered by analysts at ATB Capital from C$4.00 to C$3.20 in a research report issued to clients and investors on Monday,BayStreet.CA reports. The firm presently has an “underperform” rating on the stock. ATB Capital’s price target suggests a potential upside of 13.48% from the stock’s current price.
Separately, Canaccord Genuity Group reduced their price objective on Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research note on Monday. Four research analysts have rated the stock with a sell rating and one has assigned a hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Reduce” and an average price target of C$5.40.
Read Our Latest Research Report on Canopy Growth
Canopy Growth Stock Performance
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Featured Stories
- Five stocks we like better than Canopy Growth
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 5 discounted opportunities for dividend growth investors
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Options Trading – Understanding Strike Price
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.